Elevar Therapeutics
Candice Athans has extensive work experience in the legal field. Candice is currently working as a Senior Corporate Paralegal at Elevar Therapeutics since September 2022. Prior to this, Candice worked at BDP International for nearly 9 years, starting in February 2013. During their time there, they held several roles, including Corporate Compliance Manager from April 2019 to September 2022, Legal Department Manager & Global Paralegal from October 2015 to September 2022, and Paralegal from February 2013 to September 2022. Before joining BDP International, they worked as a Paralegal at Console Law Offices from May 2012 to February 2013.
Candice Athans obtained a Certification in Paralegal Studies from Peirce College, which they pursued from 2011 to 2012. Prior to that, they pursued a Bachelor's degree in Political Science and Legal Analysis from Widener University, which they completed between 2007 and 2011. In addition to their formal education, Candice has obtained a Notary Public certification from the New Jersey Notary in October 2022. Candice also holds a Paralegal certification, however, the institution and date of obtaining this certification are unknown.
This person is not in any offices
Elevar Therapeutics
Elevar Therapeutics is a pharmaceutical company that specializes in the development of therapies for unmet medical needs in cancer. The company is developing two proprietary drug candidates; rivoceranib (Apatinib), a VEGFR-2 inhibitor which has demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with thepotential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent.Elevar Therapeutics holds worldwide rights for rivoceranib excluding China and has partnered for development and marketing in South Korea.